ECOR
electroCore, Inc.
$10.25
+0.69%
$85.0M
No data for this timeframe.
Vol
Market Cap$85.0M
Cap SizeMicro Cap
Inst. Holders15 funds
Inst. Value$3.1M
Inst. Activity0 buys / 1 sells
Insider Activity1B / 3S
Insider Net $-$116.4K
SEC Reports5
Press Releases3
Exchange Nasdaq·Sector Electromedical & Electrotherapeutic Apparatus·Inc. DE·CIK 0001560258·Prev Close $10.18
Recent Activity
Jun 2, 2026
other
electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub
<p>ROCKAWAY, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracke
May 28, 2026
Insider
Lev Joshua S. sold 6,667 shares
CFO and Interim President @ $9.00 ($60.0K)
May 27, 2026
SEC
Director Thomas M. Patton filed a Form 144 indicating intent to sell 85,000 shares of electroCore (ECOR) valued at appro
144 — Impact 2/10
May 22, 2026
Insider
Lev Joshua S. sold 3,000 shares
CFO and Interim President @ $6.50 ($19.5K)
May 21, 2026
Insider
Errico Thomas J. bought 9,992 shares
Director @ $5.99 ($59.9K)
May 14, 2026
SEC
Director Daniel S. Goldberger filed a Form 144 to sell 45,000 shares of electroCore common stock, valued at approximatel
144 — Impact 2/10
May 5, 2026
SEC
Insider Daniel S. Goldberger (likely an officer/director) filed a Form 144 to sell 25,000 shares of ECOR, valued at appr
144 — Impact 4/10
Inst.
MORGAN STANLEY — NEAR_EXIT
367 shares ($2.2K)
Price Targets
Historical data — last covering-analyst action Jan 2026. No current recommendation available.
$19.17 (Jan 2026)
Current $10.25
Low $12.00
Median $19.85
High $26.00
5 analysts
$12.00
$26.00
Analyst Ratings
3Strong Buy
7Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jan 26, 2026 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.41 ▼ -13.1% | $-0.50 — $-0.31 | 6% YoY | 5 |
| Next Q | $-0.29 ▲ +3.1% | $-0.36 — $-0.23 | 28% YoY | 5 |
| Current FY | $-1.50 ▼ -4.0% | $-1.61 — $-1.43 | 9% YoY | 5 |
| Next FY | $-0.43 ▲ +25.4% | $-0.87 — $0.35 | 71% YoY | 4 |
Latest Reports
NEUTRAL
144
2/10
Director Thomas M. Patton filed a Form 144 indicating intent to sell 85,000 shares of electroCore (ECOR) valued at appro
May 27, 2026
NEUTRAL
144
2/10
Director Daniel S. Goldberger filed a Form 144 to sell 45,000 shares of electroCore common stock, valued at approximatel
May 14, 2026
MIXED
Press
5/10
electroCore announced the publication of a post-hoc clinical analysis showing potential benefits of its non-invasive vag
Apr 1, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.2M | — |
| BALYASNY ASSET MANAGEMENT L.P. | $702.3K | — |
| RENAISSANCE TECHNOLOGIES LLC | $267.8K | TRIM |
| VANGUARD FIDUCIARY TRUST CO | $232.3K | — |
| HighTower Advisors, LLC | $213.1K | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 28, 2026 | Lev Joshua | SELL | $60.0K |
| May 22, 2026 | Lev Joshua | SELL | $19.5K |
| May 21, 2026 | Errico Thomas | BUY | $59.9K |
| May 20, 2026 | Errico Thomas | L | $47.84 |
| Apr 13, 2026 | Fox Michael | A | $0.00 |
15 institutional holders with $3.1M total value (516,269 shares) as of 2026-Q1. Top holders: VANGUARD, BALYASNY, RENAISSANCE. Net selling activity: 1 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 202,644 | $1.2M | 39.3% | — |
| 2 | BALYASNY ASSET MANAGEMENT L.P. | 116,463 | $702.3K | 22.6% | — |
| 3 | RENAISSANCE TECHNOLOGIES LLC | 44,409 | $267.8K | 8.6% | TRIM -45.7% |
| 4 | VANGUARD FIDUCIARY TRUST CO | 38,528 | $232.3K | 7.5% | — |
| 5 | HighTower Advisors, LLC | 35,342 | $213.1K | 6.8% | — |
| 6 | BlackRock, Inc. | 26,776 | $161.5K | 5.2% | DOUBLED +196.7% |
| 7 | STATE STREET CORP | 26,518 | $159.9K | 5.1% | ADD +25.3% |
| 8 | TWO SIGMA INVESTMENTS, LP | 19,121 | $115.3K | 3.7% | — |
| 9 | ROYAL BANK OF CANADA | 2,000 | $12.0K | 0.4% | — |
| 10 | Rockefeller Capital Management L.P. | 1,946 | $11.7K | 0.4% | — |
| 11 | Vanguard Global Advisers, LLC | 1,771 | $10.7K | 0.3% | — |
| 12 | MORGAN STANLEY | 367 | $2.2K | 0.1% | NEAR_EXIT -91.3% |
| 13 | WELLS FARGO & COMPANY/MN | 311 | $1.9K | 0.1% | — |
| 14 | Allworth Financial LP | 72 | $435.00 | 0.0% | — |
| 15 | CITIGROUP INC | 1 | $6.00 | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | NEAR_EXIT | 4,202 | 367 | -91.3% | $2.2K | 2026-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 100,286 | 54,486 | -45.7% | $244.4K | 2025-Q4 |
| MORGAN STANLEY | DOUBLED | 1,425 | 4,202 | +194.9% | $18.8K | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 180,686 | 100,286 | -44.5% | $496.4K | 2025-Q3 |
| MORGAN STANLEY | NEAR_EXIT | 18,476 | 1,425 | -92.3% | $7.1K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | 107 | 6 | -94.4% | $30.00 | 2025-Q3 |
| STATE STREET CORP | ADD | 21,172 | 26,518 | +25.3% | $140.0K | 2025-Q2 |
| UBS Group AG | ADD | 5,471 | 8,978 | +64.1% | $47.4K | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 131,786 | 178,425 | +35.4% | $1.2M | 2025-Q1 |
| STATE STREET CORP | TRIM | 36,272 | 21,172 | -41.6% | $141.6K | 2025-Q1 |
| UBS Group AG | DOUBLED | 793 | 5,471 | +589.9% | $36.6K | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 72,986 | 131,786 | +80.6% | $2.1M | 2024-Q4 |
| STATE STREET CORP | DOUBLED | 11,672 | 36,272 | +210.8% | $588.0K | 2024-Q4 |
| BlackRock, Inc. | DOUBLED | 11,581 | 34,357 | +196.7% | $556.9K | 2024-Q4 |
| MORGAN STANLEY | DOUBLED | 174 | 15,441 | +8774.1% | $250.3K | 2024-Q4 |
| UBS Group AG | TRIM | 1,692 | 793 | -53.1% | $12.9K | 2024-Q4 |
| BANK OF AMERICA CORP /DE/ | NEAR_EXIT | 172 | 42 | -75.6% | $681.00 | 2024-Q4 |
| MORGAN STANLEY | DOUBLED | 1 | 174 | +17300.0% | $1.3K | 2024-Q3 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 50 | 172 | +244.0% | $1.2K | 2024-Q3 |
4 unique insiders with 9 transactions. Net insider value: -$116.4K ($59.9K bought, $176.3K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 28, 2026 | Lev Joshua S. | CFO and Interim President | SELL | 6,667 | $9.00 | $60.0K |
| May 22, 2026 | Lev Joshua S. | CFO and Interim President | SELL | 3,000 | $6.50 | $19.5K |
| May 21, 2026 | Errico Thomas J. | Director | BUY | 9,992 | $5.99 | $59.9K |
| May 20, 2026 | Errico Thomas J. | Director | L | 8 | $5.98 | $47.84 |
| Apr 13, 2026 | Fox Michael | Chief Operating Officer | AWARD | 70,000 | — | — |
| Apr 10, 2026 | Goldberger Daniel S | SELL | 16,072 | $6.02 | $96.8K | |
| Apr 1, 2026 | Lev Joshua S. | CFO and Interim President | AWARD | 45,000 | — | — |
| Mar 19, 2026 | Errico Thomas J. | Director | EXERCISE | 22,803 | — | — |
| Mar 19, 2026 | Errico Thomas J. | Director | EXERCISE | 22,803 | $4.35 | $99.2K |
5 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 5 neutral. Avg impact: 2.4/10.
NEUTRAL
144
2/10
Director Thomas M. Patton filed a Form 144 indicating intent to sell 85,000 shares of electroCore (E
May 27, 2026
NEUTRAL
144
2/10
Director Daniel S. Goldberger filed a Form 144 to sell 45,000 shares of electroCore common stock, va
May 14, 2026
NEUTRAL
144
4/10
Insider Daniel S. Goldberger (likely an officer/director) filed a Form 144 to sell 25,000 shares of
May 5, 2026
NEUTRAL
PRESS-RELEASE
1/10
electroCore announces it will report Q1 2026 financial results after market close on May 6, 2026. No
Apr 29, 2026
NEUTRAL
144
3/10
Daniel S. Goldberger, former CEO of electroCore, Inc., filed a Form 144 to sell up to 10,000 shares
Apr 23, 2026
MIXED
5/10
electroCore announced the publication of a post-hoc clinical analysis showing potential benefits of
Apr 1, 2026
MIXED
6/10
electroCore reported record full-year 2025 revenue of $32.0 million, a 27% increase from 2024, drive
Mar 19, 2026
NEUTRAL
3/10
electroCore, Inc. announced management participation in the upcoming 38th Annual Roth Conference, wh
Mar 10, 2026
Historical analyst distribution (last covering-analyst action Jan 2026): 91% buy across 11 analysts — 3 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Jan 2026. No current recommendation available.
$19.17 mean target (Jan 2026)
$12.00 Low
$26.00 High
| Metric | Value |
|---|---|
| Current Price | $10.25 |
| Target Low | $12.00 |
| Target Mean | $19.17 |
| Target Median | $19.85 |
| Target High | $26.00 |
| # Analysts | 5 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.41 | $-0.50 | $-0.31 | 5.9% | -13.1% | 1↑ 4↓ | $0.0B | 30.8% | 5 |
| Next Q 2026-09-30 |
$-0.29 | $-0.36 | $-0.23 | 28.5% | +3.1% | 1↑ 2↓ | $0.0B | 24.9% | 5 |
| Current FY 2026-12-31 |
$-1.50 | $-1.61 | $-1.43 | 9.1% | -4.0% | 1↑ 3↓ | $0.0B | 30.9% | 5 |
| Next FY 2027-12-31 |
$-0.43 | $-0.87 | $0.35 | 71.0% | +25.4% | 1↑ 2↓ | $0.1B | 29.3% | 4 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.414 | |
| 7d ago | $-0.412 | -0.002 |
| 30d ago | $-0.366 | -0.048 |
| 60d ago | $-0.370 | -0.044 |
| 90d ago | $-0.360 | -0.054 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jan 26, 2026 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 7 | 1 | 0 | 0 | 91% | |
| May 1, 2026 | 3 | 7 | 1 | 0 | 0 | 91% | |
| Apr 1, 2026 | 3 | 7 | 1 | 0 | 0 | 91% | |
| Mar 1, 2026 | 3 | 7 | 1 | 0 | 0 | 91% | |
| Feb 1, 2026 | 3 | 7 | 1 | 0 | 0 | 91% | |
| Jan 1, 2026 | 3 | 7 | 1 | 0 | 0 | 91% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 2, 2026
other
electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub
<p>ROCKAWAY, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=08MrtQLPsWyilQqy4g1aHTo_2bhFwlm1YvDRSZ07J86
May 9, 2026
other
electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026
<p>ROCKAWAY, N.J., May 08, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company
May 5, 2026
earnings_calendar
ECOR Q1 2026 Earnings Scheduled — 2026-05-05
Apr 29, 2026
earnings
electroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026
<p>ROCKAWAY, N.J., April 29, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness compa
Apr 28, 2026
other
electroCore to Present at the Market Movers Investor Summit on May 5, 2026
<p>ROCKAWAY, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness compa
Apr 23, 2026
other
electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation
<p align="justify">ROCKAWAY, N.J., April 23, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine an
Apr 1, 2026
fda
electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD
<p>ROCKAWAY, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness compa
Mar 19, 2026
earnings
electroCore Announces Full Year 2025 Financial Results and Organizational Changes
<p align="center"><em>Record f</em><em>ull year 2025 net sales of {{SSR_CONTENT}}lt;/em><em>32.0</em><em>, an increase of 27% over $25.2 million for the full year 202
Mar 10, 2026
earnings
electroCore to Participate at the 38th Annual Roth Conference
<p>ROCKAWAY, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine and wellness company, announced tod
Mar 10, 2026
earnings_calendar
ECOR Q4 2025 Earnings After Market Close — 2026-03-10